1. Stocks
  2. Dogwood Therapeutics Inc.
  3. Swot
swot-logo

Dogwood Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Dogwood Therapeutics Inc. has 14 Strengths, 6 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Rising Momentum: Momentum Score Weekly Gainers

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over Half Year (6 Months)

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Overbought by Money Flow Index (MFI)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Top Losers

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks